Dr Jane Beith MBBS, FRACP, PhD

Dr Beith is a Senior Staff Specialist in Medical Oncology at Sydney Cancer Centre, Royal Prince Alfred Hospital.  She graduated from the University of Sydney in 1985 and completed her Medical Oncology training at Royal North Shore Hospital.  Dr Beith worked overseas at University College Hospital, London and obtained a PhD in assessing and modulating drug resistance to nitrosureas.

Dr Beith was appointed at Royal Prince Alfred Hospital in 1996 and has established a busy practice in the management of melanoma and woman's cancer (breast and gynaecological malignancies).  She is a principal investigator on a number of clinical trials, and has a particular interest in survivorship after treatment for early stage breast cancer.

Dr Beith is also on a number of Advisory Boards giving scientific advice about further clinical trials and marketing.

Dr Anne Hamilton MBBS, FRACP, DES

Dr Hamilton joined the Sydney Cancer Centre as a Staff Specialist in Medical Oncology in November 2002.  Anne is an active clinical researcher in the fields of women's cancers (breast and gynaecological malignancies), melanoma and new drug development.  She has more than 20 peer-reviewed publications and is an investigator on a number of early phase clinical studies through her participation in US National Cancer Institute-sponsored research groups, including the CTEP Organ Dysfunction Working Group, and Cornell University's Phase II consortium.  As a medical oncologist, Dr Hamilton specialises in breast cancer, gynaecological cancers and melanoma.

Professor Peter Hersey

Professor Hersey was appointed Professor of Oncology at the University of Newcastle in 1984 and currently holds the positions of Research Director of the Newcastle Melanoma Unit and Consultant Immunologist to the MIA.  He is a Member of the WHO Melanoma study group, the Society of Biological Therapy, the National Cancer Research Advisory Group and Cancer Care Australia.  He is Chairman of the Melanoma and Skin Cancer Group of the Clinical Oncology Society of Australia.

Professor Hersey was the principal investigator of a large Australian trial of adjuvant immunotherapy and is principal investigator in a dendritic cell vaccine trial in melanoma.  Since 1998 he has contributed extensively to studies on sensitivity of Melanoma cells to apoptosis induced by the immune system and treatments which sensitise melanoma to therapy.

Professor Hersey is on the editorial board of a number of international journals and has contributed extensively to melanoma research.  He is author of over 200 papers on original research related to melanoma.  Clinical research is conducted by Professor Hersey through the MIA and the Newcastle Melanoma Unit.

Professor Richard Kefford

Professor Kefford is Director of Clinical research for the MIA. He is Professor of Medicine at the University of Sydney and Director of the Westmead Institute for Cancer Research, where much of the laboratory-based research of MIA is conducted. He is Chair of the Division of Medicine, Westmead Hospital and Consultant Medical Oncologist to the MIA where he is involved in the conduct of a large number of clinical trials of new anti-melanoma drugs.

Associate Professor Fran Boyle AM MBBS (QLD) FRACP PhD

Associate Professor Boyle is a Medical Oncologist at North Sydney’s Mater Hospital, where she is Director of the Patricia Ritchie Centre for Cancer Care and Research, and Associate Professor of Medical Oncology at the University of Sydney.

Associate Professor Boyle graduated from University of QLD Medical School with Honours and a University Medal. She undertook her initial physician training at the Mater in Brisbane, before transferring to Royal North Shore Hospital in Sydney to complete her Medical Oncology training and a PhD in Pharmacology.

Associate Professor Boyle's clinical practice focuses on breast cancer and melanoma, in association with the newly formed Melanoma Institute of Australia at the Mater. Her current research interests include clinical trials of new cancer treatments, psychosocial and supportive care and communication.

Associate Professor Boyle was honoured with Membership of the Order of Australia in 2008 for services to cancer research, advocacy, policy development and professional education.

Dr Georgina Long

Dr Catriona McNeil